期刊文献+

联合检测抗酿酒酵母菌抗体和中性粒细胞胞浆抗体在炎症性肠病中的临床意义 被引量:1

原文传递
导出
摘要 目的联合检测抗酿酒酵母抗体(ASCA-IgG、IgA)和核周型抗中性粒细胞胞浆抗体(pANCA)水平,探索对克罗恩病(CD)和溃疡性结肠炎(UC)诊断和鉴别诊断的意义。方法应用ELISA法和间接免疫荧光法检测9例CD,10例UC患者及18例健康对照组的ASCA-IgA及PANCA水平。结果9例CD ASCA-IgG和ASCA-IgA水平(酶单位)为18.51±6.38和11.74±5.46,10例UC为6.98±5.24和3.88±3.52以及18名健康对照者5.90±4.12和4.26±3.21(P〈0.05)。pANCA UC敏感性为80%,而CD和健康对照者阳性率为0%。结论ASCA是一种对CD具有特异性的抗体,pASCA是与UC呈正相关的一个免疫学指标。
出处 《中国医师杂志》 CAS 2007年第10期1418-1419,共2页 Journal of Chinese Physician
  • 相关文献

参考文献6

  • 1欧阳钦,潘国宗,温忠慧,万学红,胡仁伟,林三仁,胡品津.对炎症性肠病诊断治疗规范的建议[J].中华消化杂志,2001,21(4):236-239. 被引量:1124
  • 2Sutton CL ,Yang H, Li Z, et al. Familial expression of anti-saccharomyces cerevisiae mannan antibodies in affected and unaffected relative of pa- tients with Crohn's disease. Gut, 2000, 46:58-63.
  • 3Vermeire S, Joossens S, Peeterts M, et al. Commparative study of ASCA (anti-saccharomyces cerevisiae antibidy ) assays in inflammatory bowel disease. Gastroenterology, 2001, 120:827-833.
  • 4Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001,96:730-734.
  • 5Walker LJ, Aldhous MC, Drummond HE, et al. Auti-saccharomyces cerevisiae antibodise (ASCA) in Crohng disease are associated with disease severity but not NOD2/CARD15 mutations. Clin Exp Immunol, 2004,135:490-496.
  • 6郑家驹,皇甫照.酿酒酵母菌抗体(ASCA)与克罗恩病[J].现代消化及介入诊疗,2004,9(4):189-191. 被引量:5

二级参考文献13

  • 1[5]Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 2001;357:1925-1928.
  • 2[6]Annese V, Andreoli A, Andriulli A, et al. Familial expression of anti-saccharomyces cerevisiae mannan antibodies in Crohn' s disease and ulcerative colitis: a GISC study. Am J Gastroenterol2001;96:2407-2412.
  • 3[7]Mow WS, Vasiliauskas EA, Lin YC, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology 2004;126:414-424.
  • 4[8]Vermeire S, Joossens S, Peeters M, et al. Commparative study of ASCA (Anti-saccharomyces cerevisiae antibody) assays in inflammatory bowel disease. Gastroenterology 2001;120:827-833.
  • 5[9]Sendid B, Quinton JF, Charrier G, et al. Anti-saccharomyces cerevisiae mannan antibodyies in familial Crohn's disease. Am J Gastroenterol 1998;93:1306-1310.
  • 6[10]Shanahan F. Inflammatory bowel disease: Immunodiagnostics,Immunotherapeutics, and Ecotherapeutics. Gastroenterology 2001;120:622-635.
  • 7[11]Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000;119:15-22.
  • 8[12]Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of antisaccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol2001 ;96: 730-734.
  • 9[13]Nielsen OH, Vainer B, Madsen SM, et al. Established and emerging biological activity markers of inflammatory bowel disease. Am J Gastroenterol 2000;95:359-367.
  • 10[1]Sutton CL, Li Z, Rotter JI, et al. Familial expression of antisaccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease. Gut 2000;46:58-63.

共引文献1127

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部